These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1774181)

  • 21. Hypnotic susceptibility as a predictor of participation in student activities.
    Graham KR; Marra LC; Rudski JM
    Am J Clin Hypn; 2003 Oct; 46(2):139-45. PubMed ID: 14609299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenomenological experiences associated with hypnotic susceptibility.
    Varga K; Józsa E; Bányai EI; Gösi-Greguss AC; Kumar VK
    Int J Clin Exp Hypn; 2001 Jan; 49(1):19-29. PubMed ID: 11190789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect scales of hypnotic susceptibility: resistance to therapy and psychometric comparability.
    Robin BR; Kumar VK; Pekala RJ
    Int J Clin Exp Hypn; 2005 Apr; 53(2):135-47. PubMed ID: 16025732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can hypnotic susceptibility be explained by bifactor models? Structural equation modeling of the Harvard group scale of hypnotic susceptibility - Form A.
    Zahedi A; Sommer W
    Conscious Cogn; 2022 Mar; 99():103289. PubMed ID: 35193060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finnish norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Kallio SP; Ihamuotila MJ
    Int J Clin Exp Hypn; 1999 Jul; 47(3):227-35. PubMed ID: 10616256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Romanian norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    David D; Montgomery G; Holdevici I
    Int J Clin Exp Hypn; 2003 Jan; 51(1):66-76. PubMed ID: 12825919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of a confusion technique on hypnotic responsivity in low-susceptible subjects.
    Stanger T; Tucker CM; Morgan JI
    Am J Clin Hypn; 1996 Jan; 38(3):214-8. PubMed ID: 8712164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polish norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Siuta J
    Int J Clin Exp Hypn; 2010 Oct; 58(4):433-43. PubMed ID: 20799122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Harvard Group Scale of Hypnotic Susceptibility and related instruments: individual and group administrations.
    Angelini FJ; Kumar VK; Chandler L
    Int J Clin Exp Hypn; 1999 Jul; 47(3):236-50. PubMed ID: 10616257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of question format on resistance to misleading postevent information and self-reports of events occurring during hypnosis.
    Eisen ML; Oustinovskaya M; Kistorian R; Morgan DY; Mickes L
    Int J Clin Exp Hypn; 2008 Apr; 56(2):198-213. PubMed ID: 18307129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on age, hypnotic suggestibility, and gender: a brief report.
    Page RA; Green JP
    Am J Clin Hypn; 2007 Apr; 49(4):283-7. PubMed ID: 17444365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Israeli norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Lichtenberg P
    Int J Clin Exp Hypn; 2008 Oct; 56(4):384-93. PubMed ID: 18726804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Harvard Group Scale of Hypnotic Susceptibility: accuracy of self-report and the memory for items.
    Younger J; Kemmerer DD; Winkel JD; Nash MR
    Int J Clin Exp Hypn; 2005 Jul; 53(3):306-20. PubMed ID: 16076667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A validation study of a short-form hypnotic-experience questionnaire and its relationship to hypnotizability.
    Matheson G; Shue KL; Bart C
    Am J Clin Hypn; 1989 Jul; 32(1):17-26. PubMed ID: 2773816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. French Norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Anlló H; Becchio J; Sackur J
    Int J Clin Exp Hypn; 2017; 65(2):241-255. PubMed ID: 28230464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting hypnotic susceptibility via a phenomenological approach.
    Forbes EJ; Pekala RJ
    Psychol Rep; 1993 Dec; 73(3 Pt 2):1251-6. PubMed ID: 8115579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypnosis and attention deficits after closed head injury.
    Laidlaw TM
    Int J Clin Exp Hypn; 1993 Apr; 41(2):97-111. PubMed ID: 8468107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of preventive measures in reducing aftereffects to hypnosis.
    Page RA; Handley GW
    Am J Clin Hypn; 1993 Jul; 36(1):26-37. PubMed ID: 8368193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short, unobtrusive hypnotic-assessment procedure for assessing hypnotizability level: I. Development and research.
    Pekala RJ
    Am J Clin Hypn; 1995 Apr; 37(4):271-83. PubMed ID: 7741083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGSHS-5:G-First results with the short version of the test for the Harvard Group Scale of Hypnotic Susceptibility and a comparison with the full version.
    Zech N; Riegel B; Rasch B; Peter B; Hansen E
    Front Psychol; 2024; 15():1422920. PubMed ID: 39144596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.